Supernus Pharmaceuticals, Inc. (SUPN)

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $165.45M in the quarter ending June 30, 2025, a decrease of -1.71%. This brings the company's revenue in the last twelve months to $665.13M, up 5.55% year-over-year. In the year 2024, Supernus Pharmaceuticals had annual revenue of $661.82M with 8.94% growth.

• Revenue (ttm): $665.13M
• Revenue Growth: +5.55%
• P/S Ratio: 3.83
• Revenue / Employee: $986,832
• Employees: 674
• Market Cap: 2.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	661.82M	54.30M	8.94%
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	15.09%
Dec 31, 2021	579.78M	59.38M	11.41%
Dec 31, 2020	520.40M	127.64M	32.50%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.